EWM
PRAH

Executive Wealth Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Executive Wealth Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8,576
Closed -$1.42M – 197
2021
Q2 		$1.42M Buy
8,576
+889
+12% +$148K 0.16% 103
2021
Q1 		$1.18M Buy
7,687
+1,804
+31% +$245K 0.14% 106
2020
Q4 		$737K Buy
5,883
+604
+11% +$67.5K 0.09% 107
2020
Q3 		$535K Buy
5,279
+439
+9% +$44.8K 0.07% 112
2020
Q2 		$470K Sell
4,840
-3,633
-43% -$338K 0.07% 100
2020
Q1 		$703K Sell
8,473
-2,009
-19% -$196K 0.12% 88
2019
Q4 		$1.17M Sell
10,482
-687
-6% -$70.7K 0.16% 91
2019
Q3 		$1.11M Buy
11,169
+139
+1% +$13.8K 0.17% 85
2019
Q2 		$1.09M Buy
11,030
+1,510
+16% +$144K 0.15% 103
2019
Q1 		$1.05M Sell
9,520
-249
-3% -$26K 0.19% 91
2018
Q4 		$898K Buy
+9,769
New +$988K 0.16% 84

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Executive Wealth Management's PRAH Position: Q3 2021 in Review

Executive Wealth Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 8,576 shares — an estimated $1.42M sold.

Executive Wealth Management first reported a position in PRAH in Q4 2018 and held it in 11 quarters. The position peaked at $1.42M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Executive Wealth Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Executive Wealth Management sold 8,576 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $1.42M.
  • Executive Wealth Management first reported a position in PRA Health Sciences, Inc. in Q4 2018 and held it in 11 quarters.
  • Executive Wealth Management's PRA Health Sciences, Inc. position peaked at $1.42M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Executive Wealth Management's 13F filing for Q3 2021, filed 27 Oct 2021.